We are live on
!
Find out more
SP
Sage Partners Portfolio holdings
AUM
$23K
This Fund
S&P 500
This Quarter
Est. Return
-65.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33K
AUM Growth
-$12.9M
(-100%)
Cap. Flow
-$8.55M
Cap. Flow
% of AUM
-25,923.1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBP
NovaBridge Biosciences American Depositary Shares
NBP
|
+$5.07M |
| 2 |
Zai Lab
ZLAB
|
+$1.82M |
| 3 |
BNR
Burning Rock Biotech
BNR
|
+$1.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
MGPI
ICMH
DB
FRCMI
FM
ACMV
NAM
AP
Sage Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Sage Partners held 3 positions worth $33K, down 100% from $13M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Sage Partners withdrew a net $8.55M in Q1 2022, closing 2 positions and reducing 1 holding. Its most notable exit was Zai Lab, an estimated $1.82M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Sage Partners's biggest Q1 2022 reduction was NovaBridge Biosciences American Depositary Shares, cutting an estimated $5.07M.
- Sage Partners fully exited Zai Lab in Q1 2022, selling an estimated $1.82M.
- Sage Partners's ten largest holdings make up 100% of its $33K portfolio in Q1 2022.
- Sage Partners opened 0 new positions and closed 2 in Q1 2022.
- Sage Partners's portfolio value fell 100% quarter-over-quarter to $33K.
Based on Sage Partners's 13F filing for Q1 2022, filed 4 May 2022.